Safety and tolerability of single and repeat doses of GSK2798745 in healthy subjects as assessed by vital signs Up to 17 Weeks [clinicaltrials_resource:a7d1d68b19b92db19573093e23d7cf80]
Vital sign measurements will include systolic and diastolic blood pressure, heart rate, and respiratory rate
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Safety and tolerability of single and repeat doses of GSK2798745 in healthy subjects as assessed by vital signs Up to 17 Weeks [clinicaltrials_resource:a7d1d68b19b92db19573093e23d7cf80]
Vital sign measurements will include systolic and diastolic blood pressure, heart rate, and respiratory rate
Bio2RDF identifier
a7d1d68b19b92db19573093e23d7cf80
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a7d1d68b19b92db19573093e23d7cf80
measure [clinicaltrials_vocabulary:measure]
Safety and tolerability of sin ...... cts as assessed by vital signs
time frame [clinicaltrials_vocabulary:time-frame]
Up to 17 Weeks
description
Vital sign measurements will i ...... art rate, and respiratory rate
identifier
clinicaltrials_resource:a7d1d68b19b92db19573093e23d7cf80
title
Safety and tolerability of sin ...... by vital signs Up to 17 Weeks
@en
type
label
Safety and tolerability of sin ...... 1d68b19b92db19573093e23d7cf80]
@en